About this trial

The purpose of this study is to evaluate the safety and performance of Cook's various Custom-Made Stent-graft Devices (CMD) used for endovascular treatment of the aorta and related diseases by collecting information on the real-world use of the devices.

The study results will be used to support the continuation of the CMDs on the market. In addition, the study will support the manufacturers obligation for post market product surveillance as well as Cook's technology development.

Eligibility criteria

Qualifiers

None

Disqualifiers

Patients who declare they are unable to complete clinical follow-up visit at the time of enrollment, or

Patients or his/her legally authorized representative objects to extraction of patient's data from the medical record, or unwilling to sign the Informed Consent.

Trial design

Treatments tested in this trial

  • Endovascular Aortic Treatments

Treatment groups

No treatment groups listed

Locations

18
Denmark
Aarhus University Hospital8200, AarhusDenmark, Denmark
Rigshospitalet2100, CopenhagenDenmark, Denmark
France
Hopital Marie Lannelongue92350, Le Plessis-Robinson France
CHU de Lille59037, Lille France

Sponsors and collaborators

Cook Research Incorporated

Lead sponsor